Abstract:Pairwise compatibility between virus and host proteins can dictate the outcome of infection. During transmission, both inter- and intraspecies variabilities in receptor protein sequences can impact cell susceptibility. Many viruses possess mutable viral entry proteins and the patterns of host compatibility can shift as the viral protein sequence changes. This combinatorial sequence space between virus and host is poorly understood, as traditional experimental approaches lack the throughput to simultaneously test all possible combinations of protein sequences. Here, we created a pseudotyped virus infection assay where a multiplexed target-cell library of host receptor variants can be assayed simultaneously using a DNA barcode sequencing readout. We applied this assay to test a panel of 30 ACE2 orthologs or human sequence mutants for infectability by the original SARS-CoV-2 spike protein or the Alpha, Beta, Gamma, Delta, and Omicron BA1 variant spikes. We compared these results to an analysis of the structural shifts that occurred for each variant spike's interface with human ACE2. Mutated residues were directly involved in the largest shifts, although there were also widespread indirect effects altering interface structure. The N501Y substitution in spike conferred a large structural shift for interaction with ACE2, which was partially recreated by indirect distal substitutions in Delta, which does not harbor N501Y. The structural shifts from N501Y greatly influenced the set of animal orthologs the variant spike was capable of interacting with. Out of the thirteen non-human orthologs, ten exhibited unique patterns of variant-specific compatibility, demonstrating that spike sequence changes during human transmission can toggle ACE2 compatibility and potential susceptibility of other animal species, and cumulatively increase overall compatibilities as new variants emerge. These experiments provide a blueprint for similar large-scale assessments of protein compatibility during entry by diverse viruses. This dataset demonstrates the complex compatibility relationships that occur between variable interacting host and virus proteins. The proteins encoded by a viral pathogen must be compatible with the proteins encoded by the host organism to allow the virus to enter and take over their cells. As the SARS-CoV-2 pandemic progressed, various SARS-CoV-2 variants of concern emerged, each altering the sequence of their spike proteins. We developed a new high-throughput infection assay which allowed us to simultaneously test dozens of sequence variants of ACE2 for their ability to allow viral particles coated with the spike proteins from the SARS-CoV-2 variants of concern to enter the cell. We found that the SARS-CoV-2 variant spike proteins only slightly changed in the way they interacted with human ACE2 but exhibited more pronounced changes in their ability to interact with ACE2 versions from other species. The SARS-CoV-2 spike variants generated during the pandemic were collectively compatible with the majority of animal ACE2 sequence versions we tested. We speculate that similar molecular interplays may occur during cross-species transmission, where repeated transmission and escape from immune responses allows the virus to simultaneously explore new molecular compatibilities with different receptor protein versions, thus allowing spread to new species.

SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption

SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants

Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16

SARS‐CoV‐2 NSP12 utilizes various host splicing factors for replication and splicing regulation

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization

The NSP4 T492I Mutation Increases SARS-CoV-2 Infectivity by Altering Non-Structural Protein Cleavage

Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages

The key features of SARS-CoV-2 leader and NSP1 required for viral escape of NSP1-mediated repression

Adaptive Evolution of the Spike Protein in Coronaviruses

Characterization of SARS-CoV-2 Variants N501Y.V1 and N501Y.V2 Spike on Viral Infectivity

Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage

Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry

Evolution of enhanced innate immune evasion by SARS-CoV-2

The Host Interactome of Spike Expands the Tropism of SARS-CoV-2

Biological Significance of the Genomic Variation and Structural Dynamics of SARS-CoV-2 B.1.617

Prion-like Domains in Spike Protein of SARS-CoV-2 Differ across Its Variants and Enable Changes in Affinity to ACE2

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2

Nasopharyngeal specific selection and emergence of SARS-CoV-2 spike fusion peptide mutation P812S during chronic infection

Molecular Epidemiology Analysis of Early Variants of SARS-CoV-2 Reveals the Potential Impact of Mutations P504L and Y541C (NSP13) in the Clinical COVID-19 Outcomes.

Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage